Anthera Pharmaceuticals Inc
SEC CIK 1316175 · ANTH · last insider filing 2018-09-12
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mcmanigle Mark Drew | Director · Chief Liquidating Officer | filed 2018 - 2018 |
| Truex Paul F | Director · President and Chief Executive | filed 2010 - 2018 |
| Shanahan William R JR | Director · Chief Medical Officer | filed 2016 - 2018 |
| Henney Christopher S | Director | filed 2010 - 2018 |
| Thompson David E. | Director | filed 2010 - 2018 |
| Thompson John Craig | Director · President & COO | filed 2016 - 2018 |
| Mueller Brian | Director | filed 2014 - 2018 |
| Furse Brent | Director | filed 2016 - 2018 |
| Sager Philip | Director | filed 2014 - 2018 |
| Engle Steven B | Director | filed 2014 - 2016 |
| Odink Debra | Director · VP, Pharmaceutical R&D | filed 2010 - 2015 |
| Zweifach Sanford S | Director | filed 2013 - 2015 |
| Spiegelman Daniel K | Director | filed 2010 - 2014 |
| Dziurzynski Bogdan | Director | filed 2012 - 2013 |
| Healy James | Director | filed 2010 - 2013 |
| Isaly Samuel D | Director | filed 2010 - 2013 |
| Orbimed Advisors LLC | Director | filed 2010 - 2013 |
| Orbimed Capital GP IV LLC | Director | filed 2010 - 2013 |
| Thompson Peter A. | Director | filed 2011 - 2012 |
| Santel Donald J | Director | filed 2010 - 2011 |
| Bianchi Annette | Director | filed 2010 - 2011 |
| Leheny A. Rachel | Director | filed 2010 - 2010 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| LIU MAY | SVP, Finance & Administration | filed 2013 - 2018 |
| Dickinson Klara | SVP & Chief Regulatory Officer | filed 2015 - 2017 |
| Olson Charles V | Chief Technology Officer | filed 2016 - 2017 |
| Pennington James | Interim Chief Medical Officer | filed 2016 - 2016 |
| Hislop Colin | Sr. VP, Cardiovasc. Prod. | filed 2010 - 2016 |
| Lowe Christopher P. | VP of Administration and CBO | filed 2010 - 2013 |
| Kilfoil Georgina | SVP,Product Dev.& Project Mgmt | filed 2010 - 2013 |
| Trias Joaquim | Sr. VP, Preclinical Developmen | filed 2010 - 2010 |
| Fritsch Ursula | VP, Glob. Reg. and Compliance | filed 2010 - 2010 |
| Lau Stephen | VP, Corp. & Business Dev. | filed 2010 - 2010 |
| Pennington James E | Chief Medical Officer & Ex. VP | filed 2010 - 2010 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.